2m 2m 2m 2m 2m 2m 2m
Medpace Holdings (MEDP)
NASDAQ
$473.19+$17.52 (+3.85%)
Price as of Jun 23, 2026 4:36 PM EDT- $13.0BMarket Cap
- 47.63%1-Year Change
- Diagnostics & ResearchIndustry
Medpace Holdings (MEDP)
$473.19+$17.52 (+3.85%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 53.2M -97.48% | 2.1B +11.84% | 1.9B +29.17% | 1.5B +27.80% | |
Cost of Revenue | 732.1M -49.60% | 1.5B +6.71% | 1.4B +32.48% | 1.0B +26.20% | |
Gross Profit | -678.9M -203.45% | 656.3M +25.13% | 524.5M +21.29% | 432.4M +31.78% | |
Sales and Marketing Expense | 197.6M +9.64% | 180.2M +11.67% | 161.4M +22.79% | 131.4M +21.19% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 946,000 -34.44% | 1.4M -34.38% | 2.2M -34.40% | 3.4M -34.45% | |
Total Operating Expenses | 2.0B +20.04% | 1.7B +7.31% | 1.5B +31.13% | 1.2B +25.17% | |
Operating Profit | 534.9M +19.71% | 446.9M +32.67% | 336.8M +20.86% | 278.7M +40.32% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -488,000 -83.20% | -2.9M +2,666.67% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -488,000 -83.20% | -2.9M +2,666.67% | |
Total Nonoperating Income and Expense | 7.4M -74.38% | 29.1M +2,641.73% | -1.1M -127.46% | 4.2M +28.61% | |
Income before Taxes | 542.4M +13.96% | 475.9M +41.78% | 335.7M +18.67% | 282.9M +40.13% | |
Income Taxes | 91.3M +27.56% | 71.5M +35.30% | 52.9M +41.02% | 37.5M +87.42% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 451.1M +11.56% | 404.4M +42.99% | 282.8M +15.26% | 245.4M +34.93% | |
Net Income from Continuing Operations Applicable to Common | 542.4M +13.96% | 475.9M +41.78% | 335.7M +18.67% | 282.9M +40.13% | |
Basic EPS and Net Income | 15.64 +19.75% | 13.06 +41.96% | 9.20 +21.53% | 7.57 +49.60% | |
Diluted EPS and Net Income | 15.28 +20.98% | 12.63 +42.23% | 8.88 +21.98% | 7.28 +51.35% | |
Basic Weighted Average Shares | 28.8M -6.82% | 31.0M +0.76% | 30.7M -5.14% | 32.4M -9.69% | |
Diluted Weighted Average Shares | 29.5M -7.77% | 32.0M +0.54% | 31.8M -5.43% | 33.7M -10.68% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 497.0M -25.75% | 669.4M +172.74% | 245.4M +768.38% | 28.3M -93.87% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 497.0M -25.75% | 669.4M +172.74% | 245.4M +768.38% | 28.3M -93.87% | |
Total Current Assets | 989.6M -3.85% | 1.0B +73.32% | 593.8M +77.81% | 334.0M -51.66% | |
Accumulated Depreciation | 123.3M +24.68% | 98.9M +24.51% | 79.4M +27.83% | 62.1M +21.56% | |
Property and Plant and Equipment and Net | 131.1M +6.02% | 123.6M +2.51% | 120.6M +9.78% | 109.8M +17.92% | |
Total Long-Term Assets | 21.9M -1.42% | 22.3M -10.88% | 25.0M +18.18% | 21.1M +21.28% | |
Total Assets | 2.0B -5.97% | 2.1B +26.80% | 1.7B +22.50% | 1.4B -18.52% | |
Income Taxes Payable | 1.4M -24.72% | 1.8M -25.12% | 2.4M +124.67% | 1.1M -0.93% | |
Total Short-Term Debt | 0 N/A | N/A N/A | 0 -100.00% | 50.0M N/A | |
Total Current Liabilities | 1.3B +21.66% | 1.1B +19.39% | 925.1M +15.14% | 803.5M +44.19% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 57.7M +34.92% | 42.7M +51.43% | 28.2M +24.32% | 22.7M +27.93% | |
Total Liabilities | 1.5B +18.90% | 1.3B +16.16% | 1.1B +13.64% | 966.1M +36.65% | |
Retained Earnings | -460.0M -5,732.19% | 8.2M +103.68% | -221.6M -38.40% | -359.8M -253.13% | |
Total Stockholders Equity | 459.1M -44.39% | 825.5M +47.70% | 559.0M +44.66% | 386.4M -59.45% | |
Total Shares Outstanding | 28.4M -7.38% | 30.6M -0.40% | 30.8M -1.09% | 31.1M -13.65% | |
Cash Flow | |||||
Cash from Operating Activities | 713.2M +17.15% | 608.8M +40.48% | 433.4M +11.68% | 388.1M +47.36% | |
Capital Expenditures | 31.4M -14.21% | 36.5M -0.27% | 36.6M -0.63% | 36.9M +30.45% | |
Cash from Investing Activities | -31.1M +10.00% | -28.3M -18.25% | -34.6M -10.62% | -38.7M +23.52% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -860.4M +458.66% | -154.0M -15.68% | -182.6M -76.46% | -775.8M +1,645.16% | |
Financials Ratio | |||||
Gross Margin | -1,276.18% -4,201.03% | 31.12% +11.89% | 27.81% -6.10% | 29.62% +3.11% | |
Operating Margin | 1,005.52% +4,645.65% | 21.19% +18.63% | 17.86% -6.43% | 19.09% +9.79% | |
Return on Assets | 22.13% +2.84% | 21.52% +14.51% | 18.80% +15.38% | 16.29% +36.64% | |
Return on Equity | 70.23% +20.23% | 58.42% -2.37% | 59.83% +63.30% | 36.64% +77.18% | |
Revenue Growth | -97.48% -923.55% | 11.84% -59.42% | 29.17% +4.91% | 27.80% +18.94% | |
Current Ratio | 0.74 -20.96% | 0.93 +45.16% | 0.64 +54.45% | 0.42 -66.48% | |
Cash Ratio | 0.37 -38.97% | 0.61 +128.46% | 0.27 +653.69% | 0.04 -95.75% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow